FR2290219A1 - Principe actif de vaccin antipyocyanique - Google Patents

Principe actif de vaccin antipyocyanique

Info

Publication number
FR2290219A1
FR2290219A1 FR7436747A FR7436747A FR2290219A1 FR 2290219 A1 FR2290219 A1 FR 2290219A1 FR 7436747 A FR7436747 A FR 7436747A FR 7436747 A FR7436747 A FR 7436747A FR 2290219 A1 FR2290219 A1 FR 2290219A1
Authority
FR
France
Prior art keywords
vaccine
liq
vaccines
bacterium
collecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7436747A
Other languages
English (en)
French (fr)
Other versions
FR2290219B1 (enExample
Inventor
P Berche
R Tinelli
M Veron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to FR7436747A priority Critical patent/FR2290219A1/fr
Publication of FR2290219A1 publication Critical patent/FR2290219A1/fr
Application granted granted Critical
Publication of FR2290219B1 publication Critical patent/FR2290219B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR7436747A 1974-11-05 1974-11-05 Principe actif de vaccin antipyocyanique Granted FR2290219A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7436747A FR2290219A1 (fr) 1974-11-05 1974-11-05 Principe actif de vaccin antipyocyanique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7436747A FR2290219A1 (fr) 1974-11-05 1974-11-05 Principe actif de vaccin antipyocyanique

Publications (2)

Publication Number Publication Date
FR2290219A1 true FR2290219A1 (fr) 1976-06-04
FR2290219B1 FR2290219B1 (enExample) 1978-12-29

Family

ID=9144684

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7436747A Granted FR2290219A1 (fr) 1974-11-05 1974-11-05 Principe actif de vaccin antipyocyanique

Country Status (1)

Country Link
FR (1) FR2290219A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0120532A3 (en) * 1983-03-23 1985-12-18 Brigham And Women's Hospital Mucoid exopolysaccharide vaccine against pseudomonas aeruginosa
US4702910A (en) * 1984-05-25 1987-10-27 Mitsui Toatsu Chemicals, Inc. Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for pretecting Pseudomonas aeruginosa infection
US5114712A (en) * 1985-11-14 1992-05-19 Mitsui Toatsu Chemicals, Inc. Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0120532A3 (en) * 1983-03-23 1985-12-18 Brigham And Women's Hospital Mucoid exopolysaccharide vaccine against pseudomonas aeruginosa
AU571495B2 (en) * 1983-03-23 1988-04-21 Brigham And Women's Hospital Mucoid exopolysaccharide vaccine against pseudomonas aeruginosa
US4702910A (en) * 1984-05-25 1987-10-27 Mitsui Toatsu Chemicals, Inc. Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for pretecting Pseudomonas aeruginosa infection
US5114712A (en) * 1985-11-14 1992-05-19 Mitsui Toatsu Chemicals, Inc. Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection

Also Published As

Publication number Publication date
FR2290219B1 (enExample) 1978-12-29

Similar Documents

Publication Publication Date Title
Liu et al. Exotoxins of Pseudomonas aeruginosa. II. Concentration, purification, and characterization of exotoxin A
GB1034123A (en) Absorbable prosthetic devices and surgical sutures
Hellstrom et al. Survival of Leptospira interrogans serovar pomona in an acidic soil under simulated New Zealand field conditions
GR3005297T3 (enExample)
ES8606485A1 (es) Procedimiento para preparar una solucion antigenica libre decelulas
Dubos et al. The effect of a tissue enzyme upon pneumococci
Walker A method for the isolation of toxic and immunizing fractions from bacteria of the Salmonella group
GB1384179A (en) Treatment of microorganism cells
FR2290219A1 (fr) Principe actif de vaccin antipyocyanique
Zerner et al. Acetoacetate decarboxylase. Preparation of the enzyme
Lachmann et al. Solubilization and characterization of surface antigenic components of Erysipelothrix rhusiopathiae T28
US4503036A (en) Process for producing a biochemical vaccine against Salmonella infection
Hambleton et al. Vaccine potencies of the live vaccine strain of Francisella tularensis and isolated bacterial components
HRP921354A2 (en) Matrix with cells adherently bounded to it, and the process for the production of viruses/virus antigenes
US3793150A (en) Equine strangles vaccine and method of preparing and using the same
Gil-Turnes et al. Serological characterization of strains of Moraxella bovis using double immunodiffusion
US3852420A (en) Equine strangles vaccine and method of preparing and using the same
Pappagianis et al. Preparation and Property of a Complement-fixing Antigen from Mycelia of
HAYASHI et al. STUDIES ON THIAMINASE OF THE CLOSTRIDIUM I. THIAMINASE OF CLOSTRIDIUM SPOROGENES
FR2189021A1 (en) Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
SU454251A1 (ru) Способ получени препаратов антигенов кишечных бактерий
Carson et al. Cellular disintegration with concomitant release of slime and production of extracellular mannan by Pseudomonas aeruginosa: two separate phenomena
ES8200228A1 (es) Metodo para producir preparados medicinales para el trata- miento de carcinomas
FR2091427A5 (en) Nutrient media for microorganisms - by extraction of fresh water alga
SU508509A1 (ru) Способ выделени ферментов избиомассы микроорганизмов

Legal Events

Date Code Title Description
ST Notification of lapse